← Leaderboards
Stewart C Wang
University Of Michigan At Ann Arbor
$4,596,548
Attributed
$5,752,303
Total exposure
5
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $954K · FY2019–25$1M$750K$500K$250K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
AHRQ$4,695,431 · 2
NIH$1,056,872 · 3
By mechanism
R01$5,645,553 · 3
R29$106,750 · 1
M01$0 · 1
Top collaborators
- Manjunath P Pai5 shared
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Laura Beretta$16,561,253
- Benjamin Levi$10,166,720
- Anna Sf Lok$10,814,527
- Gabriel Nunez$34,455,724
- David M. Lubman$15,307,348
Others in their field
Top investigators on “Binding Proteins”
- Barton F Haynes · Duke University$99,233,321
- David Heimbrook · Leidos Biomedical Research, Inc.$96,490,307
- Constance Ann Benson · University Of California, San Diego$65,790,143
- Michael P Snyder · Yale University$64,416,845
- Alice Telesnitsky · University Of Michigan At Ann Arbor$51,513,556
- Adam L Boxer · Mayo Clinic Rochester$51,057,712
Research focus
Binding ProteinsLipopolysaccharidesGram Negative BacteriaLaboratory RatProtein Structure FunctionInflammationWestern BlottingsImmunocytochemistryWound InfectionCytokineWound HealingEnzyme Linked Immunosorbent AssayBurnsHost Organism InteractionInjuryGene ExpressionGenetic Promoter ElementAnimal Genetic Material TagMolecular CloningNucleic Acid SequenceMultiple Organ FailureBacterial ToxinsProtein BiosynthesisKidney Cell
Grant awards (17)
Precision coordination of therapeutic and prophylactic antibiotics to reduce infection, toxicity, and emergence of resistance following acute abdominal surgery$432,590
R01 · FY2025 · HS
Precision coordination of therapeutic and prophylactic antibiotics to reduce infection, toxicity, and emergence of resistance following acute abdominal surgery$459,656
R01 · FY2024 · HS
Precision coordination of therapeutic and prophylactic antibiotics to reduce infection, toxicity, and emergence of resistance following acute abdominal surgery$471,078
R01 · FY2023 · HS
Precision Prophylaxis of Surgical Site Infection Utilizing Pharmacomorphomics$467,204
R01 · FY2023 · HS · contact PI
Precision Prophylaxis of Surgical Site Infection Utilizing Pharmacomorphomics$487,810
R01 · FY2022 · HS · contact PI
Precision coordination of therapeutic and prophylactic antibiotics to reduce infection, toxicity, and emergence of resistance following acute abdominal surgery$466,165
R01 · FY2022 · HS · contact PI
Precision coordination of therapeutic and prophylactic antibiotics to reduce infection, toxicity, and emergence of resistance following acute abdominal surgery$482,021
R01 · FY2021 · HS · contact PI
Precision Prophylaxis of Surgical Site Infection Utilizing Pharmacomorphomics$462,618
R01 · FY2021 · HS · contact PI
Precision Prophylaxis of Surgical Site Infection Utilizing Pharmacomorphomics$487,168
R01 · FY2020 · HS · contact PI
Precision Prophylaxis of Surgical Site Infection Utilizing Pharmacomorphomics$479,121
R01 · FY2019 · HS · contact PI
WOUND RESPONSE TO INFECTION: ROLE OF LPS-BINDING PROTEIN$247,897
R01 · FY2003 · GM
WOUND RESPONSE TO INFECTION: ROLE OF LPS-BINDING PROTEIN$240,744
R01 · FY2002 · GM
Trauma &organ failure--Role of local LPS binding protein$0
M01 · FY2002 · RR
WOUND RESPONSE TO INFECTION: ROLE OF LPS-BINDING PROTEIN$233,799
R01 · FY2001 · GM
WOUND RESPONSE TO INFECTION: ROLE OF LPS-BINDING PROTEIN$227,682
R01 · FY2000 · GM
TRAUMA &ORGAN FAILURE--ROLE OF LPS BINDING PROTEIN$106,750
R29 · FY2000 · GM
Trauma &organ failure--Role of local LPS binding protein$0
M01 · FY2000 · RR